To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
about
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
description
clinical trial
@en
klinisch onderzoek
@nl
name
To Evaluate the Safety and Tol ...... cipants With Episodic Migraine
@en
type
label
To Evaluate the Safety and Tol ...... cipants With Episodic Migraine
@en
prefLabel
To Evaluate the Safety and Tol ...... cipants With Episodic Migraine
@en
P6153
P1476
A Phase 3, Multicenter, Random ...... th Episodic Migraine (Advance)
@en
P3098
NCT03777059
P580
2018-12-14T00:00:00Z
P582
2020-02-05T00:00:00Z